SCHEMBL25826586

SCHEMBL25826586

N#Cc1ccc2nccc(Nc3ccc(C(=O)Nc4ccc(Nc5ccccc5)cc4)nc3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 6/20 0.51
DNMT3A Q9Y6K1 5/20 0.51
MAPKAPK2 P49137 3/20 0.51
DNMT3L Q9UJW3 2/20 0.50
GAK O14976 1/20 0.48
RIPK2 O43353 1/20 0.48
COQ8A Q8NI60 1/20 0.48
NLK Q9UBE8 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
GRM4 Q14833 1/20 0.46
MAPT P10636 3/20 0.45
USP2 O75604 2/20 0.45
KMT2A Q03164 2/20 0.45
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
PRKAA2 P54646 2/20 0.43
IDO1 P14902 1/20 0.43
TDO2 P48775 1/20 0.43
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30180452 0.92 MAPT (0.54) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL19151512 0.92 MAPT (0.54) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL24003814 0.90 DNMT1 (0.49) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL30180621 0.89 DNMT1 (0.65) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL23999573 0.89 DNMT1 (0.65) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
Trifluoroacetic Acid SCHEMBL28974304 0.88 MAPT (0.49) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
Trifluoroacetic Acid SCHEMBL30180324 0.88 MAPT (0.49) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL23999494 0.87 GAK (0.54) MAPKAPK2GAKRIPK2COQ8ANLK
SCHEMBL24006169 0.86 DNMT1 (0.70) DNMT1DNMT3AMAPKAPK2DNMT3LGAK
SCHEMBL25825392 0.86 DNMT1 (0.54) DNMT1DNMT3AMAPKAPK2DNMT3LGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4785/4885DNMT3A 4693/4885MAPKAPK2 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.